Introduction

59
Cardiovascular diseases (CVD) which include coronary heart disease (myocardial infarction and 60 angina), stroke and peripheral vascular disease (1) are a key contributor to the burden of disease 61 globally (2) . Over the past 50 years, the prevalence of CVD has fallen in Western populations, 62 however, CVD are currently the major cause of death in women in the UK, accounting for 32% of 63 all deaths (3) . Furthermore, the prevalence of CVD is dramatically increasing in other areas, 64 including Eastern Europe, Asia and the Indian subcontinent (4) . 3 progressive endothelial dysfunction (characterised by a loss of vascular wall homeostasis leading to 70 a decrease in vascular reactivity and raised blood pressure) in both sexes, although it appears to 71 occur earlier in men than women (7) . The most prominent sex related difference in physiological 72 ageing is the menopause (cessation of menstruation) in women, which usually occurs between the 73 ages of 45 and 55 y, with 51 y being the average age of menopause in the UK (8) . This natural part 74 of aging in women contributes a significant cardiovascular milestone in terms of both physiology 75 and pathology since oestrogen deficiency is known to impair lipid metabolism and endothelial 76 function, and the menopause is a recognised risk factor for CVD (9) . It has further been shown by 77 Schouw et al. (10) that for each year of delay in the age of onset of the natural menopause, CVD risk 78 falls by 2%. 79 
80
Postprandial lipaemia 81 Kolovou et al. defined postprandial lipaemia as a complex syndrome characterised by non-fasting 82 hypertriacylglycerolaemia and its augmentation is associated with increased risk of cardiovascular 83 events (11) . Following a fat containing meal, there is a transient rise in circulating triacylglycerol 84 (TAG) rich lipoproteins (TRL), such as chylomicrons (CM) and very low density lipoprotein 85 (VLDL). After entering the circulation, the CM TAG is hydrolysed into non-esterified fatty acids receptor mediated uptake (12) . A delayed clearance of TRLs in the circulation enhances the HDL particles make them suitable substrates for LPL and hepatic lipase, leading to the formation of 99 smaller denser LDL (LDL3) and HDL (HDL3) particles (13) . HDL3 is rapidly removed from the 100 circulation decreasing circulating HDL cholesterol (HDL-C) concentrations, which is one proposed 101 mechanism for the inverse association between exaggerated postprandial lipaemia and CVD risk 102 (14) . Another possible mechanism is that LDL3 has a lower binding affinity to the LDL-receptor, 4 reducing their rate of clearance from the circulation and enabling them to infiltrate the arterial wall 104 (13) .
Since atherosclerosis is now also considered to be a postprandial phenomenon, three large
106
prospective cohort studies aimed to determine the link between cardiovascular events and non-107 fasting TAG (15; 16; 17) . In the Norwegian Counties Study, hazard ratios of 1.2 and 1.03 for deaths 108 from CVD per 1 mmol/l increase in non-fasting TAG were reported in women and men, 109 respectively, after 27 years of follow up in a total of 86,261 participants (17) . Furthermore, the
110
Copenhagen City Heart Study that followed 7581 women and 6391 men for 31 years showed that 111 relative to women with non-fasting TAG of <1 mmol/L, hazard ratios for myocardial infarction 112 ranged from 1.5 for women with TAG between 1.0-1.99 mmol/L rising to 4.2 for those with TAG
113
≥5 mmol/L (16) . However, the corresponding hazard ratios for men were 1. declining as the fasting time increased (15) . These studies have demonstrated the greater importance 119 of non-fasting than fasting TAG concentrations as a predictor of CVD risk in women than men.
120
The relationship between postprandial lipaemia and CVD according to menopausal status is lipaemic responses have been reported in a number of studies (18; 19; 20; 21) (Supplemental material 1).
123
In general, premenopausal women have lower postprandial triacylglycerol (TAG) responses than 124 men (22; 23; 24; 25) , which is in contrast to the higher reported responses observed in postmenopausal 125 women compared with men of a similar age (26) . (20) , Schoppen et al. (19) and 132 Jackson et al. (21) also reported significantly higher postprandial TAG responses after single and 133 sequential fat-rich test meals in healthy postmenopausal women. Although raised LDL cholesterol
134
(LDL-C) is an established risk factor for CVD, large prospective studies have shown non-fasting
135
TAG to be a better predictor of CVD risk in women than fasting LDL-C (27; 28; 29) . Post-hoc analysis of the The Dietary Studies: Reading Unilever Postprandial Trials (DISRUPT) menopausal groups 137 according to age also revealed a greater increase in non-fasting TAG than fasting LDL-C during the late premenopausal period suggesting that age and the menopause have a differential impact on 139 these two lipid CVD risk biomarkers (21) .
140
A major biochemical change that occurs in women after the menopause is a reduction in the 141 secretion of endogenous oestrogen and progesterone (30) . (34) . One possible mechanism to explain this effect, that
150
was identified in in vitro animal studies, was an increase in the number of high affinity LDL
151
receptors on liver cell membranes that enhance LDL uptake by the liver (33) . Exaggerated
152
postprandial lipaemia is observed after the menopause (18) but the administration of even short term
153
(two to six weeks) oestradiol therapy reduces the menopause-related rise in postprandial TAG in 154 postmenopausal women (35; 36) . These findings indicate that 17β-estradiol may accelerate the function, including hypertension (37; 38) , arterial stiffness (39) and impaired endothelial dependent 160 vasodilation (endothelial dysfunction) (40; 41) , are all associated with cardiovascular mortality. In a 161 healthy blood vessel, the endothelium, which is comprised of a monolayer of endothelial cells that It does so by maintaining a precise balance between the release of endothelium-derived vasodilators
165
(such as nitric oxide (NO)), and vasoconstrictors (such as endothelin-I), which actively regulates 166 vascular permeability to plasma constituents, platelets and leukocyte adhesion molecules (42) as well 167 as aggregation and thrombosis (43) . However, when the production or bioavailability of NO is 168 reduced, the resulting imbalance of these vasoactive substances disrupts vascular homeostasis. This
169
'endothelial dysfunction' is characterised by vasoconstriction, increased expression of adhesion 170 molecules and pro-inflammatory cytokines, platelet activation and increased oxidative stress (44) , 171 and is becoming increasingly recognised as an important step for the initiation of coronary 172 atherosclerosis (45) and CVD risk in postmenopausal women (46) . There is supporting evidence of 6 impaired endothelial function after the menopause, which has been associated with a lack of 174 endogenous oestrogen (7; 47) .
There are a number of non-invasive methods which are used to evaluate endothelial function endothelium-dependent vasodilation in the conduit arteries in the peripheral circulation and is used 178 as a surrogate measure of NO production (49) . It is now recognised as a screening tool to assess women, respectively (52) . This suggests the perimenopausal stage (the transition towards the 185 menopause where oestrogen production starts to fall) is a crucial turning point in women where 186 changes in CVD risk commence.
187
Majmudar et al. (53) revealed that menopausal status is associated with reduced NO activity,
188
which is restored with oestrogen replacement therapy and may be an important mechanism 189 facilitating the detrimental effect of the menopause on CVD risk and mortality. Another study that effects on forearm microvascular responses to both endothelium-dependent (acetylcholine) and -
192
independent vasodilation (sodium nitroprusside) via improvements in NO activity (54) . Impaired
193
blood flow in the microcirculation has been proposed to be an indicator of initial endothelial 194 damage in subjects at risk of CVD (55) . Furthermore, it has been repeatedly shown that 17β-
195
oestradiol stimulates the production of vasodilatory prostaglandins, such as prostacyclin (PGI2) (56; 196 57) . These vascular effects are believed to be partly responsible for the long-term benefit of events to increase following the long-term (>1 y) use of oestrogen therapy (60) . In contrast, there is 204 much evidence to suggest that oestrogens (endogenous and exogenous) have several cardio-
205
protective effects ( Figure 1 ) (32; 61; 62) . These include reductions in plasma markers of endothelial 206 activation (E-selectin) and increased fibrinolytic activity (increased factor VII; reduced fibrinogen, 7 plasminogen activator inhibitor type 1 and tissue plasminogen activator) (32; 63) . However, increased 208 markers of inflammation (C-reactive protein) and hypercoagulability have also been reported (32; 61) .
209
Hypertension (high blood pressure) is one of the main age-related disorders in 210 postmenopausal women (64; 65) , which has been identified as a leading risk factor for myocardial 211 infarction and stroke in women (66) . The renin-angiotensin system (RAS) is a hormonal cascade,
212
which plays a key role in the regulation of fluid and electrolyte balance, and arterial blood pressure.
213
Upon activation of the RAS cascade, angiotensin II is produced in the liver by angiotensin-214 converting enzyme (ACE) following conversion of angiotensin I to angiotensin II (67) . Angiotensin
215
II is a potent vasoconstrictor which degrades bradykinin (a vasodilator) causing arterioles to 216 constrict, resulting in increased blood pressure (68) . oestrogen and the activation of RAS (72; 73; 74; 75) . This has been proposed to occur due to oestrogen oxygen species (ROS) generation, and endothelial cell apoptosis (76; 77; 78) . Oestrogen deficiency has 228 also been reported to lead to an upregulation of ACE activity causing an accumulation of 229 angiotensin II (79) .
231
Impact of meal fat composition on postprandial lipaemia and vascular function 232
Diet is one of the most important modifiable risk factors in relation to CVD (80) . As a strategy to 233 reduce the incidence of CVD, public health policy makers recommend that intakes of dietary 234 saturated fatty acids (SFA) are reduced to <10% total energy in the UK (81) . reduction in total fat intake, may reduce cardiovascular events by 14% (82) . Since individuals spend The chronic effects of substitution of SFA with polyunsaturated fat (PUFA) on fasting lipid 243 levels have been extensively studied (83) , however, the acute affects are less well known. One 244 systematic review and meta-analysis of RCT compared the effects of oral fat tolerance tests with 245 differing fatty acid compositions on postprandial TAG responses in men and women (84) . Relative to by Monfort-Pires et al. (84) none of the studies included postmenopausal women which reflects the 252 paucity of postprandial data in this population subgroup.
253
With regards to vascular function, West and colleagues (85) reported that consumption of a free radicals by accelerating the rate of β-oxidation of free fatty acids (e.g. superoxide radicals).
258
Increased production of ROS or free radicals reduce the amount of bioactive NO by chemical 259 inactivation to form toxic peroxynitrite (90) . In addition, it has been shown that persisting oxidative 260 stress will render endothelial nitric oxide synthase dysfunctional, markedly reducing NO production 261 (91) . Indeed, high concentrations of TRLs during the postprandial state enhance inflammation by 262 inducing the secretion of pro-inflammatory cytokines (92) and expression of soluble cell adhesion 263 molecules (93) .
264
Reviews by Hall (94) and Vafeiadou et al. (95) an understudied group within the population at increased CVD risk.
9
Subjects and methods
278
A systematic approach was used to identify all relevant published literature according to the method 279 used by Vafeiadou et al. (95) . (99) .
324
Data on these human studies will be presented in two sections that address the effects of (Table 1) . Furthermore, Pirro et al. including increases in apo B-48 (102) , glucose (103) , and insulin (103) as well as reductions in HDL (99; 103; 104) , glutathione (101) and NEFA (103) were also observed postprandially compared with fasting Table 1 , only one study that was described in three publications compared the postprandial lipaemic responses to 348 test meals containing oils rich in SFA (palm oil), MUFA (olive oil), n-6 PUFA (safflower oil) and a 349 mixture of n-6 PUFA and n-3 PUFA (safflower and fish oils) (97; 98; 100) . In this study, 10 . Although Robertson et al. (100) did not determine the specific fatty acid composition of 356 the circulating NEFA after consumption of the meals, a similar study reported the postprandial 357 change in the plasma NEFA profile to represent the fatty acid composition of the test meals (105) . profiles between the four different test oils (98) . In particular, the MUFA meal resulted in the 362 formation of a greater number of both large (Svedberg flotation rate (Sf>400 fraction) and 363 moderately (Sf 60-400 fraction) sized apo B-48 particles compared with the other three study meals.
364
The findings from this study suggested that olive oil may enhance CM formation and Jackson et al.
365 (97) hypothesised that MUFA may modify the activity or expression of intestinal microsomal TAG 366 transfer protein, which is involved with TRL lipoprotein assembly.
368
Acute effects of meal fat composition on vascular function
369
Only one study has also examined the acute impact of total fat and/or SFA and/or MUFA and/or n-6
370
PUFA on vascular reactivity in postmenopausal women. A significant decrease in the %FMD 371 response at 2 h (2.3 ± 2.6%) compared with baseline (7.7 ± 2.8%, p < 0.05) was observed in healthy 372 postmenopausal women after a 65 g oral fat load with a PUFA:SFA ratio of 0.06 (101) (Table 1) .
373
Since a comparator meal of a different fatty acid composition was not included in this study, women cannot be determined. 
